Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-10

Clinical Trial Update: Vinpocetine in Patients With Parkinsonian Disease [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating vinpocetine in patients with Parkinson's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vinpocetine (vinpocetine)

Snippet

Sponsor: Tanta University | Conditions: Parkinson Disease | Phase 2, Phase 3 | Status: RECRUITING